 |
PDBsum entry 6vpy
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Immune system
|
PDB id
|
|
|
|
6vpy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
The effects of framework mutations at the variable domain interface on antibody affinity maturation in an HIV-1 broadly neutralizing antibody lineage.
|
 |
|
Authors
|
 |
J.O.Zhou,
H.A.Zaidi,
T.Ton,
D.Fera.
|
 |
|
Ref.
|
 |
Front Immunol, 2020,
11,
1529.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Understanding affinity maturation of antibodies that can target many variants of
HIV-1 is important for vaccine development. While the antigen-binding site of
antibodies is known to mutate throughout the co-evolution of antibodies and
viruses in infected individuals, the roles of the mutations in the antibody
framework region are not well understood. Throughout affinity maturation, the
CH103 broadly neutralizing antibody lineage, from an individual designated
CH505, altered the orientation of one of its antibody variable domains. The
change in orientation was a response to insertions in the variable loop 5 (V5)
of the HIV envelope. In this study, we generated CH103 lineage antibody variants
in which residues in the variable domain interface were mutated, and measured
the binding to both autologous and heterologous HIV-1 envelopes. Our data show
that very few mutations in an early intermediate antibody of the lineage can
improve binding toward both autologous and heterologous HIV-1 envelopes. We also
crystallized an antibody mutant to show that framework mutations alone can
result in a shift in relative orientations of the variable domains. Taken
together, our results demonstrate the functional importance of residues located
outside the antigen-binding site in affinity maturation.
|
 |
|
|
|
|
 |